NUCLEAR PHARMACY CONFERENCE (Pharmacist)
Sunday, October 6, 2024
Advancements in Pulmonary Imaging – It’s Here – Exploring Technegas
8:00am-9:30am
Vesper Grantham, MEd, RT(N), CNMT, Chair, Medical Imaging and Radiation Sciences, Program Director, Nuclear Medicine
Upon completion of this activity, participants will be able to: Describe the protocol features of Technegas including equipment, radiopharmaceutical administration, and imaging protocol; Discuss the advantages of Technegas over traditional ventilation imaging agents; Evaluate implementation of Technegas for nuclear medicine departments.
UAN: 0675-0000-24-035-L01-P
The U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Use of Isotopes (ACMUI)
9:30am - 11:00am
Richard Green, BSPharm, RPh, BCNP FAPhA,
Upon completion of this activity, participants will be able to: Discuss the ACMUI role in the NRC; Describe the current make-up of the ACMUI membership; Discuss the topics recently taken up by the ACMUI; Identify areas of future NRC action as a result of ACMUI reports.
UAN: 0675-0000-24-036-L03-P
Radiotherapeutics: Best Practice and Updates
11:15am-12:45pm
Akram Hussein, PharmD, MBA, BCNP, Director – Nuclear Medicine Radiopharmacy, MD Anderson Cancer Center
Upon completion of this activity, participants will be able to: Describe the tools and infrastructure needed for a successful radiotherapeutics program; Discuss how a commercial and hospital nuclear pharmacist can support a theranostics center; Explain medical events related to radiotherapies and how to decrease their occurrence.
UAN: 0675-0000-24-037-L01-P
Instrument Review and Best Practices for Nuclear Pharmacy
12:45pm-2:15pm
Wendy Galbraith, PharmD, FAPhA, BCNP, Clinical Associate Professor, University of Oklahoma, Dept. of Pharmaceutical Sciences, College of Pharmacy, Nuclear Pharmacy & Research Imaging Facility
Upon completion of this activity, participants will be able to: Describe National Institute of Standards and Technology primary and secondary sources; Explain the error rate in measuring activity from various radiopharmaceuticals; Describe how to change or add a new calibration setting on the dose calibrators.
UAN: 0675-0000-24-038-L01-P
No Comments